Treatment of Chronic Heart Failure Complicated with Anxiety and Depression Using Traditional Chinese and Western Medicine

JCNR

Journal of Clinical and Nursing Research

2208-36852208-3693

Bio-Byword Scientific Publishing Pty. Ltd.

10.26689/jcnr.v6i4.3919

Article

Treatment of Chronic Heart Failure Complicated with Anxiety and Depression Using Traditional Chinese and Western Medicinehttps://artdesignp.com/journal/JCNR/6/4/10.26689/jcnr.v6i4.3919DongMili,FanHong

2022

2022-07-28

Chronic heart failure (CHF) is the terminal stage of various heart diseases, and is the main cause of death from cardiovascular disease. In recent years, the prevalence of CHF combined with anxiety and depressive state has shown an upward trend, and this paper was aimed to provide a reference for the diagnosis and treatment of CHF combined with anxiety and depression using Traditional Chinese medicine (TCM) and Western medicine.

2019, Guidelines for Rational Use of Drugs for Heart Failure (2nd Edition). Chinese Journal of Frontiers in Medicine (Electronic Edition), 11(07): 1–78.

Huang D, Zhang J, Zhou J, et al., 2020, Research Progress in the Treatment of Patients with Chronic Heart Failure with Anxiety and Depression. Advances in Cardiology, 41(3): 255–258.

Xiang Z, Tuowen, Qiu W, et al., 2019, Clinical Study on the Treatment of Chronic Heart Failure with Astragalus Baoxin Soup and Western Medicine. Shaanxi Journal of Traditional Chinese Medicine, 40(08): 1085–1087 + 1097.

Sun C, 2016, Related Studies on Coronary Heart Disease with Anxiety, Depressive State and its TCM Syndrome. Chengdu University of Traditional Chinese Medicine.

Sun S, Su W, 2021, Research Progress in the Treatment of Chronic Heart Failure Complicated by Anxiety and Depressive Disorders in Traditional Chinese Medicine. Journal of Cardiovascular and Cerebrovascular Diseases of Integrated Traditional Chinese and Western Medicine, 19(04): 590–593.

Ehlert U, Gaab J, Heinrichs M, 2001, Psychoneuroendocrinological Contributions to the Etiology of Depression, Posttraumatic Stress Disorder, and Stress-Related Bodily Disorders: The Role of the Hypothalamus-Pituitary-A Drenal Axis. Biol Psychol, 57(1–3): 141–152.

Quesseveur G, Reperant C, David DJ, et al., 2013, 5-HT2A Receptor Inactivation Potentiates the Acute Antidepressant-Like Activity of Escitalopram: Involvement of the Noradrenergic System. Exp Brain Res, 226(2): 285–295.

Sessa F, Anna V, Messina G et al., 2018, Heart Rate Variability as Predictive Factor for Sudden Cardiac Death. Aging: Albany NY, 10(2): 166–177. http://org.doi.10.18632/aging.101386

Yang R, Shi Y, Wang Q, 2022, Research Progress on the Co-Pathogenesis and Drug Treatment of Chronic Heart Failure and Depression. Chinese Journal of General Medicine, 25(05): 625–630.

Fedacko J, Singh RB, Gupta A, et al., 2014, Inflammatory Mediators in Chronic Heart Failure in North India. Acta Cardiol, 69(4): 391–398.

Kim YK, Na KS,Myint AM, et al., 2016, The Role of Pro-Inflammatory Cytokines in Neuroinflammation, Neurogenesis, and the Neuroendocrine System in Major Depression. Prog Neuropsychopharmacol Biol Psychiatry, 64(01): 277–284.

Uchmanowicz I, Gobbens RJ, 2015, The Relationship between Frailty, Anxiety, and Depression, and Health-Related Quality of Life in Elderly Patients with Heart Failure. Clin Interv aging, 10(08): 1595–1600.

Brunes A, Gudmundsdottir SL, Augestad LB, 2015, Gender-Specific Associations between Leisure-Time Physical Activity and Symptoms of Anxiety: The Hunt Study. Soc Psychiatry Psychiatr Epidemiol, 50(3): 419–427.

Friedmann E, Son H, Thomas SA, et al., 2014, Poor Social Support is Associated with Increases in Depression but Not Anxiety Over 2 Years in Heart Failure Outpatients. J Cardiovasc Nurs, 29(1): 20–28.

Teply RM, Packard KA, White ND, et al., 2016, Treatment of Depression in Patients with Concomitant Cardiac Disease. Prog Cardiovasc Dis, 58(5): 514–528.

Liao Z, Yi X, Liu X, et al., 2018, Observation on the Efficacy of Hepatic Depressive Method in the Treatment of Patients with Heart Failure Complicated by Anxiety and Depression. Clinical Research of Traditional Chinese Medicine, 10(32): 3–6.

Xue H, Zhao P, 2016, True Martial Tang Combined with Loose Addition and Subtraction for Chronic Heart Failure with Depression, Yang Qi Deficiency, and Liver Qi Depression. Chinese Journal of Experimental Formulary, 22(19): 144–148.

An B, Ji Z, Ji W, 2013, Discussion on the Idea of Wen Qian Method for the Treatment of Elderly Hypertension. Chinese Journal of Traditional Chinese Medicine, 28(1): 41–43.

Liyan, Li J, An B, et al., 2019, Discussion on the Idea of Wenyang Liqi Method in the Treatment of Chronic Heart Failure Complicated with Depression Yang Deficiency and Depression. Journal of Cardiovascular and Cerebrovascular Diseases of Integrated Traditional Chinese and Western Medicine, 17(10): 1576–1577.

Zhang P, Zhao H, Chen C, et al., 2011, Modern Literature Study on Common Symptoms and Symptomatic Elements of Chronic Heart Failure. Chinese Journal of Traditional Chinese Medicine, 26(10): 2378–2381.

Xue J, Li Q, Shen R, 2009, Clinical Observation of 30 Patients with Chronic Heart Failure and Depression Treated from Liver. Chinese Journal of Traditional Chinese Medicine Emergency, 18(11): 1753–1754.

Gu Y, Tao D, 2017, Based on the Theory of “Heart Lord God,” the Effect of Yixin Decoction on Mild Depression After Heart Failure. China Medical Herald, 14(7): 73–76.